company background image
BIOL logo

BIOLASE OTCPK:BIOL Stock Report

Last Price

US$0.077

Market Cap

US$2.7m

7D

-14.4%

1Y

-99.0%

Updated

18 Jul, 2024

Data

Company Financials +

BIOL Stock Overview

Develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally.

BIOL fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health2/6
Dividends0/6

BIOLASE, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for BIOLASE
Historical stock prices
Current Share PriceUS$0.077
52 Week HighUS$9.35
52 Week LowUS$0.036
Beta0.72
11 Month Change-40.31%
3 Month Change-44.60%
1 Year Change-98.97%
33 Year Change-99.99%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Biolase partners with dental speciality programs across U.S.

Aug 31

BIOLASE: Ongoing Operating Losses, Capital Raises To Sustain Liquidity

Jul 21

BIOLASE amends senior secured term loan with SWK Funding

Jul 01

BIOLASE: Bad News Across The Board - Sell

Mar 21

Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

Feb 24
Is BIOLASE (NASDAQ:BIOL) Weighed On By Its Debt Load?

BIOLASE - Speculative Buy After Strong Preliminary Q4 Results

Jan 11

BIOLASE - Good News Across The Board But Still Only Suited For The Most Speculative Investors

Nov 24

Is BIOLASE (NASDAQ:BIOL) Using Debt Sensibly?

Jul 14
Is BIOLASE (NASDAQ:BIOL) Using Debt Sensibly?

Biolase shares jump 11% after regaining Nasdaq compliance

Feb 04

Biolase: Business Recovery On The Way But Warrant Overhang Should Keep Investors Sidelined

Feb 01

Shareholder Returns

BIOLUS Medical EquipmentUS Market
7D-14.4%-1.5%-0.7%
1Y-99.0%-4.0%20.2%

Return vs Industry: BIOL underperformed the US Medical Equipment industry which returned -0.5% over the past year.

Return vs Market: BIOL underperformed the US Market which returned 20.5% over the past year.

Price Volatility

Is BIOL's price volatile compared to industry and market?
BIOL volatility
BIOL Average Weekly Movement27.2%
Medical Equipment Industry Average Movement8.0%
Market Average Movement5.9%
10% most volatile stocks in US Market14.9%
10% least volatile stocks in US Market2.9%

Stable Share Price: BIOL's share price has been volatile over the past 3 months.

Volatility Over Time: BIOL's weekly volatility has increased from 22% to 27% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984157John Beaverwww.biolase.com

BIOLASE, Inc., together with its subsidiaries, develops, manufactures, markets, and sells laser systems for dental practitioners and their patients in the United States and internationally. Its dental laser systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The company offers Waterlase all-tissue dental laser systems for cutting soft and hard tissues; diode soft-tissue laser systems for soft tissue, hygiene, temporary pain relief, teeth whitening, and cosmetic procedures; and Epic Hygiene laser to manage non-surgical periodontitis and enhance clinical production.

BIOLASE, Inc. Fundamentals Summary

How do BIOLASE's earnings and revenue compare to its market cap?
BIOL fundamental statistics
Market capUS$2.67m
Earnings (TTM)-US$38.25m
Revenue (TTM)US$48.83m

0.1x

P/S Ratio

-0.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BIOL income statement (TTM)
RevenueUS$48.83m
Cost of RevenueUS$32.11m
Gross ProfitUS$16.72m
Other ExpensesUS$54.98m
Earnings-US$38.25m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.15
Gross Margin34.25%
Net Profit Margin-78.35%
Debt/Equity Ratio5,207.1%

How did BIOL perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.